Skip to main navigation Skip to search Skip to main content

Scleromyxedema, a positive effect with thalidomide

Research output: Contribution to journalArticlepeer-review

Abstract

Scleromyxedema is a rare dermatological disorder marked by widespread symmetric 2- to 3-mm, firm, waxy, closely spaced papules involving the hands, forearms, face, neck, upper trunk and thighs. The most common extracutaneous manifestation of scleromyxedema is a benign plasma cell dyscrasia. Treatment of scleromyxedema is limited by the lack of long-term results, toxicity and significant adverse side effects. We report a severe case of scleromyxedema who had marked improvement when treated with thalidomide. Copyright © 2006 S. Karger AG.
Original languageEnglish
Pages (from-to)150-152
Number of pages3
JournalDermatology
Volume213
Issue number2
DOIs
StatePublished - Aug 2006
Externally publishedYes

ASJC Scopus Subject Areas

  • Dermatology

Keywords

  • Immunosuppressives
  • Scleromyxedema
  • Thalidomide
  • Severity of Illness Index
  • Thalidomide/therapeutic use
  • Follow-Up Studies
  • Paraproteins/drug effects
  • Humans
  • Middle Aged
  • Scleromyxedema/blood
  • Angiogenesis Inhibitors/therapeutic use
  • Female

Cite this